Public Company News

Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors

SHANGHAI and HONG KONG, June 8, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...

2022-06-08 08:30 3142

Innovent Announces Phase 2 study of Mazdutide(IBI362) in Chinese Participants with Overweight or Obesity Met Primary and All Key Secondary Endpoints

SAN FRANCISCO and SUZHOU, China, June 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ot...

2022-06-08 08:00 3948

66% of Australia's employees willing to forgo higher salaries or job promotions for work-life balance: Michael Page Australia

SYDNEY, June 8, 2022 /PRNewswire/ -- Sparked by the global pandemic, the Great Resignation has been happening inAustralia for the past two years and will only intensify in 2022. There has been a wave of resignations observed with almost half (42%) of employees who have been at their current jobs ...

2022-06-08 07:00 1121

THE ROYAL CANADIAN MINT REIMAGINES CLASSIC DESIGNS IN ITS LATEST COLLECTOR COIN OFFERING

OTTAWA, ON, June 8, 2022 /PRNewswire/ -- Ten years ago, the Royal Canadian Mint'sWinnipeg facility struck the last Canadian penny. Today, the Mint is releasing a 1 oz. silver collector coin edition of the penny to commemorate the decade since it last came off the press. The classic G. E. Kruger G...

2022-06-08 02:16 4747

Buybacks of series B shares in AB Electrolux during week 22, 2022

STOCKHOLM, June 7, 2022 /PRNewswire/ -- During the period May 30 - June 3, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 278,374 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize the compa...

2022-06-07 21:29 3336

Syncron Price Selected by Mitsubishi Motors Corporation to Boost Enhanced Service Parts Pricing Strategy

Leading automotive company implements Syncron Price™ to drive more efficient price management operations and further price optimization to maximize consolidated sales and profit. TOKYO, June 7, 2022 /PRNewswire/ -- Syncron, the largest privately-owned global leader in intelligent Service Lifecyc...

2022-06-07 20:05 3517

SUSE Unveils Comprehensive Infrastructure Security Stack to Enable Business Transformation

* SUSE shares its vision to strengthen security for enterprises through new open source cloud-native solutions * Industry-first partnerships with AMD, Google and NVIDIA will drive a secure software supply chain * Major updates to SUSE Linux Enterprise, SUSE Manager, Rancher and NeuVector te...

2022-06-07 20:00 2873

Futu Singapore sees 40% surge in stocks transfer-in during last two months

Futu SG (moomoo) is now offering lifetime zero commission for stocks trading across the US, HK andSingapore markets to cater the emerging demand, effective 1 June 2022.* SINGAPORE, June 7, 2022 /PRNewswire/ -- Futu Singapore Pte. Ltd. ("Futu SG (moomoo)"), a subsidiary of Nasdaq-listed andTencen...

2022-06-07 18:55 5226

SIGNATURE KITCHEN SUITE STUNS WITH ITS PRECISION AND INNOVATION AT MILAN DESIGN WEEK 2022

LG Solidifies its Ultra-Premium Status in the European Market With its High-End Built-In Kitchen Solutions SEOUL, South Korea, June 7, 2022 /PRNewswire/ -- LG Electronics (LG) will present the essence of its ultra-premium built-in kitchen appliance brand at Milan Design Week 2022, the globally-r...

2022-06-07 15:07 3628

ManpowerGroup Talent Solutions Named a Star Performer and Global Leader in Recruitment Process Outsourcing by Everest Group

Recognized for Breadth and Depth of Global Service Offerings and Advances in Business Intelligence MILWAUKEE, June 7, 2022 /PRNewswire/ -- ManpowerGroup Talent Solutions (NYSE: MAN) has been named a global leader in Recruitment Process Outsourcing (RPO) for the 12th year in the Everest Group PEA...

2022-06-07 13:01 4099

XCMG Ranks in Top Three in KHL Group's Yellow Table for Second Consecutive Year

Its Aerial Work Platform Also Ranks 5th Position in the Access M20 Manufacturers list XUZHOU, China, June 7, 2022 /PRNewswire/ -- XCMG (SHE:000425) is ranked among the top three original equipment manufacturers (OEMs) in the world for the second consecutive year, according to the Yellow Table pu...

2022-06-07 12:00 5854

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018

– Discovered in-house by the internal R&D Team at Antengene, ATG-018 is an orally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitor that targets the DNA damage response (DDR) pathway. – This Phase I study will evaluate the safety, pharmacology and prelim...

2022-06-07 11:34 3673

LONGi Founder and President Li Zhenguo advocates building a healthy planet for everyone's prosperity by providing clean, efficient and affordable energy at Stockholm +50 Conference

XI'AN, China, June 7, 2022 /PRNewswire/ -- This year is the 50th anniversary of the United Nations Conference on the Human Environment (1972-2022). To mark this occasion, the UN announced to convene the "Stockholm +50" High-level International Conference themed "A Healthy Planet for the Prosperit...

2022-06-07 09:33 2722

CStone presents pre-specified overall survival data of sugemalimab for first-line treatment of stage IV non-small cell lung cancer at ASCO 2022

* Sugemalimab is the world's first PD-L1 monoclonal antibody to show the statistically significant and clinically meaningful overall survival improvement in combination with chemotherapy for patients with treatment-naïve stage IV non-small cell lung cancer across both squamous and non-squamous ...

2022-06-07 08:02 4354

Innovent and AnHeart Jointly Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1-TKI) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

* In 67 ROS1 TKI-naïve patients, the confirmed objective response rate (cORR) and disease control rate (DCR) were 92.5% and 95.5%, respectively. * In 38 crizotinib-pretreated patients, the cORR and DCR were 50% and 78.9%, respectively. * In 12 patients with brain metastasis and measurable...

2022-06-07 08:00 4017

USI Assists Customers in Launching Cloud Gateway to Make Cloud Services Both Efficient and Intelligent

SHANGHAI, June 7, 2022 /PRNewswire/ -- Cloud Gateway allows data to shift freely between different "protocols" and helps the calculation and data transfer. Recently, USI has collaborated with customers in developing a cloud gateway that can send messages from fire alarm systems to public clouds a...

2022-06-07 07:00 5336

/C O R R E C T I O N -- Altair/

In the news release, Altair Expands Design Technology for Additive Manufacturing with Acquisition of Gamma, issued06-Jun-2022 by Altair over PR Newswire, we are advised by the company that the headline should read "Altair Expands Design Technology for Additive Manufacturing with Acquisition of Ge...

2022-06-07 06:14 5489

Telix Showcasing Innovation in Theranostics at SNMMI

MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its presence at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held inVancouver from June 11-14. Gallium-based pr...

2022-06-07 05:00 3047

Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an investigational oral selective estrogen receptor degrader (SERD), vs. investigator's choice of endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC) FLORENCE, Ita...

2022-06-06 23:07 4215

Cisco Unveils Innovations Driving New Security Cloud Strategy

News Summary: * Cisco unveiled its new strategic vision of a unified platform for end-to-end security across hybrid multi-cloud environments * The company is designing the Cisco Security Cloud to be the most open security platform with no public cloud lock-in * Cisco is taking steps to real...

2022-06-06 23:00 3577
1 ... 731732733734735736737 ... 901

Week's Top Stories